{"id":"https://openalex.org/W4379282001","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.7561","title":"Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.","display_name":"Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379282001","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.7561"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.7561","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.7561","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.7561","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088009215","display_name":"Carrie Ho","orcid":"https://orcid.org/0000-0003-4437-9377","observed_orcids":["https://orcid.org/0000-0003-4437-9377"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie Ho","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020858509","display_name":"Jonathan R. Fromm","orcid":"https://orcid.org/0000-0002-2287-5284","observed_orcids":["https://orcid.org/0000-0002-2287-5284"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan R. Fromm","raw_affiliation_strings":["Division of Hematopathology, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045975673","display_name":"Min Fang","orcid":"https://orcid.org/0000-0001-6688-437X","observed_orcids":["https://orcid.org/0000-0001-6688-437X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Fang","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037938194","display_name":"Brian G. Till","orcid":"https://orcid.org/0000-0002-4718-8288","observed_orcids":["https://orcid.org/0000-0002-4718-8288"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian G. Till","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296565","display_name":"Mazyar S. Shadman","orcid":"https://orcid.org/0000-0002-3365-6562","observed_orcids":["https://orcid.org/0000-0002-3365-6562"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazyar Shadman","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024384857","display_name":"Andrew J. Cowan","orcid":"https://orcid.org/0000-0002-1880-7094","observed_orcids":["https://orcid.org/0000-0002-1880-7094","https://orcid.org/0000-0003-2326-2727"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Cowan","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005281918","display_name":"Ryan C. Lynch","orcid":"https://orcid.org/0000-0001-6703-0894","observed_orcids":["https://orcid.org/0000-0001-6703-0894"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan C. Lynch","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109286759","display_name":"Vicky Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vicky Wu","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057524392","display_name":"Jenna M. Voutsinas","orcid":"https://orcid.org/0000-0002-7474-4892","observed_orcids":["https://orcid.org/0000-0002-7474-4892"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenna M. Voutsinas","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather A. Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather A. Rasmussen","raw_affiliation_strings":["Division of Medical Oncology, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083438","display_name":"Katharine Blue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katharine Blue","raw_affiliation_strings":["Division of Medical Oncology, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079426839","display_name":"Chaitra Shankar Ujjani","orcid":"https://orcid.org/0000-0003-1977-1510","observed_orcids":["https://orcid.org/0000-0003-1977-1510","https://orcid.org/0000-0003-2662-4826"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaitra Shankar Ujjani","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059661907","display_name":"Andrei R. Shustov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrei R. Shustov","raw_affiliation_strings":["Seagen, Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen, Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844603","display_name":"Ryan Daniel Cassaday","orcid":"https://orcid.org/0000-0002-3424-2425","observed_orcids":["https://orcid.org/0000-0002-3424-2425"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Daniel Cassaday","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088459737","display_name":"Stephen Douglas Smith","orcid":"https://orcid.org/0000-0001-5354-7593","observed_orcids":["https://orcid.org/0000-0001-5354-7593"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Douglas Smith","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"7561","last_page":"7561"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.9869999885559082},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8009999990463257},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7720000147819519},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8510000109672546},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8389999866485596},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.984000027179718},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6499999761581421},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5830000042915344},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.3869999945163727},{"id":"https://openalex.org/keywords/paraneoplastic-pemphigus","display_name":"paraneoplastic pemphigus","score":0.7680000066757202},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9042462110519409},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7371851205825806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7004461884498596},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6658819913864136},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6128960847854614},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5662815570831299},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5276039242744446},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.4748152494430542},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46305179595947266},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4350195527076721},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.391587495803833},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35945045948028564},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34209680557250977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16530513763427734},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.15394622087478638}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.7561","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.7561","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.7561","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387745534","https://openalex.org/W2950348075","https://openalex.org/W3005263041","https://openalex.org/W2921487706","https://openalex.org/W3096835610","https://openalex.org/W2594693420","https://openalex.org/W3211913577","https://openalex.org/W1454876849","https://openalex.org/W2076770812","https://openalex.org/W2913338680"],"abstract_inverted_index":{"7561":[0],"Background:":[1],"Rituximab,":[2],"cyclophosphamide,":[3],"doxorubicin,":[4],"vincristine,":[5],"and":[6,46,62,121,124,175,198,209,248,262,270,369,389],"prednisone":[7],"(R-CHOP)":[8],"represents":[9],"the":[10,187,206,295,308,346,353],"historical":[11],"1st":[12,385],"line":[13,386],"treatment":[14],"standard":[15],"for":[16,113],"DLBCL":[17,87,387],"but":[18],"fails":[19],"to":[20,94,339],"cure":[21],"about":[22],"1/3":[23],"of":[24,49,58,68,77,98,189,236,284,294,307,362,373,391],"patients.":[25,41,288],"While":[26],"generally":[27],"ineffective":[28],"in":[29,38,56,110,178,186,282,342,349,384],"relapsed":[30],"DLBCL-NOS,":[31],"checkpoint":[32],"inhibitors":[33,383],"may":[34],"have":[35,166,303,315],"greater":[36],"promise":[37],"untreated,":[39],"immunocompetent":[40],"We":[42,70],"previously":[43],"reported":[44],"safety":[45,354],"early":[47],"efficacy":[48],"pembrolizumab":[50,334],"plus":[51,335],"RCHOP,":[52],"noting":[53],"objective":[54],"responses":[55,341],"90%":[57],"patients":[59,141,225,297,310,344],"(CR":[60],"77%)":[61],"a":[63,359],"2-year":[64],"progression-free":[65],"survival":[66,122,201],"(PFS)":[67],"83%.":[69],"now":[71,152],"report":[72,161],"5":[73,331],"year":[74,332],"follow":[75,149,213,291],"up":[76,150],"our":[78,159],"study.":[79],"Methods:":[80],"Patients":[81],"age":[82],">":[83],"18":[84],"with":[85,106,145,311,326,345,358],"untreated":[86],"or":[88,365],"grade":[89,239,242,245,249,363],"3b":[90],"follicular":[91],"lymphoma,":[92],"intended":[93],"receive":[95],"6":[96,114],"cycles":[97,112],"R-CHOP,":[99],"were":[100,137,142,216,229,253],"eligible.":[101],"Pembrolizumab":[102],"200":[103],"mg":[104],"IV":[105],"R-CHOP":[107,336],"was":[108,280,324,356],"given":[109],"21-day":[111],"cycles.":[115],"For":[116],"this":[117],"updated":[118],"analysis,":[119,319],"progression":[120],"events,":[123],"immune-related":[125,219],"toxicities,":[126],"are":[127],"reported.":[128],"Additionally,":[129],"prognostic":[130],"factors":[131],"including":[132,394],"tumor":[133,278,395],"PD-L1":[134,277,301,313,320,396],"expression":[135,279,302,314],"(Qualtek/Merck)":[136],"re-analyzed.":[138],"Results:":[139],"30":[140],"treated":[143],"(13/30":[144],"IPI":[146],"3-5).":[147],"Median":[148],"is":[151,194],"4.8":[153],"years":[154],"(95%":[155],"CI,":[156],"4.5-5.4).":[157],"Since":[158],"initial":[160],"(Smith":[162],"BJH":[163],"2019)":[164],"we":[165],"observed":[167],"1":[168,183,240],"additional":[169],"relapse":[170],"(alive":[171],"after":[172,273],"CAR-T":[173],"therapy)":[174],"2":[176,243],"deaths":[177],"remission":[179],"(1":[180],"urothelial":[181],"carcinoma,":[182],"respiratory":[184],"failure":[185],"setting":[188],"progressive":[190],"ILD).":[191],"5-year":[192,199],"PFS":[193],"71%":[195],"(CI,":[196,203],"54-94%)":[197],"overall":[200],"83%":[202],"71-98%).":[204],"During":[205],"study":[207],"period":[208],"at":[210,266],"long":[211],"term":[212],"up,":[214,292],"there":[215],"8":[217],"total":[218],"adverse":[220],"events":[221],"(IRAEs)":[222],"among":[223],"7":[224],"(23%)":[226],"(Table).":[227],"Four":[228],"treatment-emergent":[230],"AE":[231],"(occurred":[232],"within":[233],"90":[234],"days":[235],"completing":[237,274],"treatment):":[238],"hyperthyroidism,":[241,244],"3":[246,250,364],"pneumonitis,":[247],"rash.":[251],"There":[252],"4":[254,309],"late":[255,374],"IRAEs:":[256],"colitis,":[257],"paraneoplastic":[258],"pemphigus,":[259],"rheumatoid":[260],"arthritis,":[261],"Graves\u2019":[263],"disease,":[264],"occurring":[265],"3,":[267],"5,":[268],"8,":[269],"46":[271],"months":[272],"treatment,":[275],"respectively.":[276],"documented":[281],"19":[283,296],"23":[285],"(83%)":[286],"tested":[287],"At":[289,330],"long-term":[290],"none":[293],"who":[298],"had":[299],"any":[300],"relapsed.":[304,316],"Two":[305],"out":[306],"no":[312,370],"On":[317],"univariate":[318],"H-score":[321],">0":[322],"(p<0.0001)":[323],"associated":[325],"improved":[327],"PFS.":[328],"Conclusions:":[329],"follow-up,":[333],"has":[337],"led":[338],"durable":[340],"most":[343],"best":[347],"outcomes":[348],"PDL1-expressing":[350],"disease.":[351],"Furthermore,":[352],"profile":[355],"manageable,":[357],"low":[360],"rate":[361],"higher":[366],"IRAEs":[367],"(10%)":[368],"consistent":[371],"pattern":[372],"events.":[375],"These":[376],"data":[377],"support":[378],"ongoing":[379],"strategies":[380],"incorporating":[381],"PD-1/PDL-1":[382],"therapy":[388],"confirmation":[390],"predictive":[392],"biomarkers":[393],"expression.":[397],"Clinical":[398],"trial":[399],"information:":[400],"NCT02541565":[401],".":[402],"[Table:":[403],"see":[404],"text]":[405]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-05T00:00:00"}